Cascade Angels Fund Invests $150K in Eugene-based NemaMetrix

Logo NemaMetrix

BEND, OR – September 17, 2015 – Cascade Angels Fund announced today that the Fund has invested $150K in Eugene-based start-up NemaMetrix. The company, which emerged from research initiated at the University of Oregon, provides technology for drug testing or biological discovery using nematode worms as a proxy for human research subjects.

Subscribe to RSS - NemaMetrix